Exosome-Functionalized Ceramic Bone Substitute Promotes Critical-Sized Bone Defect Repair in Rats

Bone autografts remain the gold standard for bone defect repair, but their use is limited by donor site morbidity and supply constraints. Ceramic biomaterials offer a promising alternative due to their structural and biocompatible properties. However, these materials often lack sufficient bioactivity to support robust bone regeneration. To address this, researchers frequently incorporate bioactive molecules or cells into ceramic scaffolds. Exosomes, as naturally occurring extracellular vesicles, have gained attention for their potential to mediate intercellular communication and promote tissue repair. Despite this, the precise mechanisms by which exosomes influence bone regeneration remain unclear. Little is known about the optimal concentration and delivery method for exosome-based therapies in bone healing. This uncertainty limits the translation of exosome research into clinical applications. Understanding how exosomes are taken up by bone-related cells and how they influence cellular behavior is essential for developing effective bone substitutes. This study aims to bridge the gap between exosome biology and their application in bone regeneration.

The researchers aimed to investigate two key aspects of exosome function in bone repair. First, they sought to determine how exosomes are internalized by bone-related cells, such as mesenchymal stem cells and preosteoblasts. Second, they examined how exosome delivery affects the behavior of these cells in vitro. The study also explored the influence of the origin of exosomes—whether from osteoblasts or mesenchymal stem cells—on their regenerative potential. Additionally, the researchers tested the effect of culturing conditions on exosome characteristics, including whether osteogenic environments alter their biological activity. A major goal was to quantify the concentration and dose of exosomes required to promote bone regeneration in a critical-sized defect model. The team used a calcium sulfate-nano-hydroxyapatite nanocement as a carrier to deliver exosomes in vivo. The ultimate objective was to assess whether exosome-loaded ceramic bone fillers could serve as a viable alternative to autografts. This approach could lead to improved strategies for bone tissue engineering.

The researchers isolated exosomes from osteoblasts and mesenchymal stem cells under both normal and osteogenic culture conditions. They labeled the exosomes with PKH-26 to track their intracellular uptake. Using fluorescence microscopy and flow cytometry, they quantified the time-dependent internalization of exosomes by mesenchymal stem cells and preosteoblasts. The team then evaluated the effect of exosome treatment on cell behavior, including proliferation and mineralization. In parallel, they prepared a calcium sulfate-nano-hydroxyapatite nanocement as a bone filler and loaded it with quantified amounts of exosomes. The exosome-loaded nanocement was implanted into critical-sized tibial defects in rats. Bone regeneration was assessed using micro-computed tomography and histological analysis. The researchers compared the outcomes of exosome-treated groups with control groups to determine the efficacy of the treatment. The study focused on both in vitro and in vivo models to provide a comprehensive evaluation of exosome function in bone repair.

Exosome treatment significantly enhanced the mineralization of preosteoblasts in vitro, as demonstrated by increased alkaline phosphatase activity and calcium deposition. The uptake of PKH-26-labeled exosomes by mesenchymal stem cells and preosteoblasts was time-dependent, with higher internalization observed at 24 hours. Exosomes derived from osteoblasts showed greater bioactivity compared to those from mesenchymal stem cells. Culturing cells under osteogenic conditions increased the expression of bone-related markers in exosome-producing cells. In vivo, the exosome-loaded nanocement promoted bone regeneration in critical-sized tibial defects. Micro-computed tomography revealed increased bone volume and connectivity in the exosome-treated group compared to controls. Histological analysis confirmed enhanced mineralization and reduced fibrous tissue formation in the treated defects. The study demonstrated that exosome delivery via a slowly resorbing nanocement can support early bone maturation and mineral deposition.

The study provides evidence that exosome-loaded ceramic bone fillers can support bone regeneration in critical-sized defects. Exosomes appear to influence preosteoblast behavior by promoting mineralization and early maturation. The use of a calcium sulfate-nano-hydroxyapatite nanocement as a carrier allows for controlled and localized exosome delivery. The results suggest that exosome therapy may offer a viable alternative to bone autografts. The findings highlight the importance of exosome origin and culture conditions in determining their bioactivity. The in vivo results confirm that exosome treatment can enhance bone mineralization and reduce fibrosis in defect sites. The study supports the potential of exosome-based therapies in bone tissue engineering. Further research is needed to optimize exosome concentration and delivery methods for clinical applications.